BR112014007684A2 - tratamento da rinite - Google Patents

tratamento da rinite

Info

Publication number
BR112014007684A2
BR112014007684A2 BR112014007684A BR112014007684A BR112014007684A2 BR 112014007684 A2 BR112014007684 A2 BR 112014007684A2 BR 112014007684 A BR112014007684 A BR 112014007684A BR 112014007684 A BR112014007684 A BR 112014007684A BR 112014007684 A2 BR112014007684 A2 BR 112014007684A2
Authority
BR
Brazil
Prior art keywords
rhinitis
pharmaceutically acceptable
acceptable salt
present
rhinitis treatment
Prior art date
Application number
BR112014007684A
Other languages
English (en)
Inventor
Bar-Or David
Original Assignee
Ampio Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ampio Pharmaceuticals Inc filed Critical Ampio Pharmaceuticals Inc
Publication of BR112014007684A2 publication Critical patent/BR112014007684A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/02—Sprayers or atomisers specially adapted for therapeutic purposes operated by air or other gas pressure applied to the liquid or other product to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

resumo patente de invenção: "tratamento da rinite". a presente invenção refere-se a um método de tratamento da rinite. o método compreende a administração de uma quantidade eficaz de um composto de danazol ou um sal farmaceuticamente aceitável do mesmo. a presente invenção também proporciona um produto farmacêutico formulado para administração nasal. o produto compreende um composto de danazol ou um sal farmaceuticamente aceitável do mesmo.
BR112014007684A 2011-10-07 2012-10-05 tratamento da rinite BR112014007684A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161544499P 2011-10-07 2011-10-07
US201161552517P 2011-10-28 2011-10-28
PCT/US2012/059061 WO2013052869A1 (en) 2011-10-07 2012-10-05 Treatment of rhinitis

Publications (1)

Publication Number Publication Date
BR112014007684A2 true BR112014007684A2 (pt) 2017-04-18

Family

ID=48044203

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014007684A BR112014007684A2 (pt) 2011-10-07 2012-10-05 tratamento da rinite

Country Status (11)

Country Link
US (1) US20140294737A1 (pt)
EP (1) EP2763678A1 (pt)
JP (1) JP2014528458A (pt)
KR (1) KR20140088542A (pt)
CN (1) CN103857398A (pt)
AU (1) AU2012318411A1 (pt)
BR (1) BR112014007684A2 (pt)
CA (1) CA2846412A1 (pt)
IL (1) IL231143A0 (pt)
MX (1) MX2014003867A (pt)
WO (1) WO2013052869A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG2014008171A (en) 2009-06-22 2014-04-28 Ampio Pharmaceuticals Inc Method for treatment of diseases
US9351979B2 (en) 2012-12-19 2016-05-31 Ampio Pharmaceuticals, Inc. Methods of treatment of diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1720573A4 (en) * 2004-02-27 2008-04-02 Centocor Inc METHODS AND COMPOSITIONS FOR TREATING PATHOLOGIES ASSOCIATED WITH IL-13
US20080066739A1 (en) * 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
US20110142914A1 (en) * 2007-12-06 2011-06-16 Cytotech Labs, Llc Inhalable compositions having enhanced bioavailability
SG2014008171A (en) * 2009-06-22 2014-04-28 Ampio Pharmaceuticals Inc Method for treatment of diseases

Also Published As

Publication number Publication date
AU2012318411A1 (en) 2014-05-29
IL231143A0 (en) 2014-04-30
CA2846412A1 (en) 2013-04-11
WO2013052869A1 (en) 2013-04-11
MX2014003867A (es) 2015-01-16
US20140294737A1 (en) 2014-10-02
KR20140088542A (ko) 2014-07-10
CN103857398A (zh) 2014-06-11
JP2014528458A (ja) 2014-10-27
EP2763678A1 (en) 2014-08-13

Similar Documents

Publication Publication Date Title
AU2018201997B2 (en) Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
BR112015029512A2 (pt) derivados de pirazolopirrolidina e seu uso no tratamento de doenças
BR112015029491A2 (pt) derivados de imidazopirrolidinona e seu uso no tratamento de doença
BR112015016911A2 (pt) tiadiazol, análogos dos mesmos e métodos de tratamento de condições relacionadas à deficiência de smn
PH12014502218A1 (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
PH12015502691A1 (en) Use of high dose pridopidine for treating huntington's disease
BR112014016085A2 (pt) composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
MX2012012225A (es) Profármacos de agentes tearapéuticos de liberación de óxido nítrico.
BR112014008036A2 (pt) tratamento de rinite
BR112013019256A2 (pt) inibição de il-17 e ifn-gama para o tratamento de inflamação autoimune
MX2014002459A (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodos de uso de los mismos.
BR112015029401A8 (pt) derivados de pirazolo-pirrolidin-4-ona, seus usos, e composição e combinação farmacêuticas
BR112015010396A2 (pt) terapia de combinação
BR112013026257A2 (pt) derivados de glicosídeo e usos dos mesmos para o tratamento de diabetes
PH12017502049A1 (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
MX2014001088A (es) Ciertos inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas, y metodos de uso de las mismas.
BR112013031652A2 (pt) métodos de tratamento para doenças retinais
BR112013021566A2 (pt) composto de fórmula, ou um aduto ou sal farmaceuticamente aceitável do mesmo e método de prevenção e/ou tratamento de um indivíduo que compreende a administração ao dito indivíduo uma quantidade terapeuticamente eficaz de um composto de fórmula
WO2013085849A3 (en) Sulfate esters of noribogaine
BR112014023423A2 (pt) terapia de combinação
BR112013029182A2 (pt) método para o tratamento de malignidades sólidas incluindo malignidades sólidas avançadas ou metastáticas
BR112013033831A2 (pt) composição farmacêutica oftalmológica tópica que contém regorafenib
BR112014004447A2 (pt) bifenilcarboxamidas como inibidores de quinase rock
EA201370230A1 (ru) Новые ингибиторы rock
BR112014004732A2 (pt) composto benzotiazolona

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]